CIBMTR Reporting Implementation Guide
0.1.6 - Trial Use 1

This page is part of the CIBMTR Reporting Implementation Guide (v0.1.6: Release Draft) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

: SNOMED Myelodysplastic Diseases - XML Representation

Active as of 2023-05-05

Raw xml | Download



<ValueSet xmlns="http://hl7.org/fhir">
  <id value="snomed-myelodysplastic-diseases-vs"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Include codes from <a href="http://www.snomed.org/"><code>http://snomed.info/sct</code></a> where concept  is-a  109995007 (Myelodysplastic syndrome (clinical))</li></ul></div>
  </text>
  <url
       value="http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/snomed-myelodysplastic-diseases-vs"/>
  <version value="0.1.6"/>
  <name value="SNOMEDMyelodysplasticDiseasesVS"/>
  <title value="SNOMED Myelodysplastic Diseases"/>
  <status value="active"/>
  <experimental value="true"/>
  <date value="2023-05-05T10:50:04-05:00"/>
  <publisher
             value="The Medical College of Wisconsin, Inc. and the National Marrow Donor Program"/>
  <contact>
    <name
          value="The Medical College of Wisconsin, Inc. and the National Marrow Donor Program"/>
    <telecom>
      <system value="url"/>
      <value value="http://www.cibmtr.org"/>
    </telecom>
  </contact>
  <contact>
    <name value="Bob Milius"/>
    <telecom>
      <system value="email"/>
      <value value="bmilius@nmdp.org"/>
    </telecom>
  </contact>
  <description
               value="The myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell diseases characterized by cytopenia(s), dysplasia (abnormal growth or development leading to an alteration in size, shape, and organization of the cell) in one or more of the major myeloid cell lines (WBC, RBC, and/or platelets), ineffective hematopoiesis, and an increased risk of developing acute myelogenous leukemia (AML). MDS occurs primarily in older adults, with a median age of 70 years. The majority of recipients present with symptoms related to cytopenias. Most recipients present with anemia requiring RBC transfusions."/>
  <compose>
    <include>
      <system value="http://snomed.info/sct"/>
      <filter>
        <property value="concept"/>
        <op value="is-a"/>
        <value value="109995007"/>
      </filter>
    </include>
  </compose>
</ValueSet>